Leela Palaces Hotels & Resorts is a luxury hospitality compounder whose economics rest on five owned palace hotels, a growing capital-light management-fee stream and a set of new brands in clubs, branded residences and wellness. The business is not a volume hotel chain. It earns a premium from location scarcity, service standards and a guest franchise that supports ADR and occupancy simultaneously. Q2 FY27 showed that model working: own hotels delivered 30% RevPAR growth on 30% ADR growth to ₹25,000 and 69% India headline occupancy, while H1 city hotel occupancy reached 74% and same-store resort occupancy nearly 60%. For April-August 2026, the India luxury market grew RevPAR 13%, Leela grew 17%, and its RevPAR index rose to 1.46x from 1.41x. That is operating evidence, not merely guidance.
The earnings base has scaled. Q2 FY27 operating revenue was ₹4,119m, up 33%, and operating EBITDA was ₹1,877m, up 36%, at a 46% margin. H1 operating revenue grew 30%, operating EBITDA 38% and margin expanded 246bps. Non-room revenue was 52% of H1 operating revenue, with Q2 F&B at ₹1,456m, up 21%. Management fees grew 76% to ₹289m after 86% growth in Q1. The direct website contributed 15.1% of room revenue, up from 10.5% a year earlier, reducing dependence on higher-cost third-party channels. The cash conversion and margin profile are the core of the compounder case: luxury hotel rooms are high-incremental-margin once occupancy is established, and non-room revenue spreads the fixed cost base.
Guidance is constructive but not a guarantee. Management says H1 was significantly ahead of its original FY27 double-digit RevPAR and mid-teens EBITDA guidance. It now guides H2 FY27 operating EBITDA growth in high teens and Q3 RevPAR growth in high double digits, and says FY27 should be much better than the original mid-teens EBITDA guide. It has not issued a new full-year number. The distinction matters: the H2 guide is explicit, while an upgraded full-year outturn is an implication, not a separately guided figure. The ₹2,000 crore FY30 EBITDA target and the over 5,200-key FY30 target are multi-year aspirations. They sit behind several years of execution and should not be treated as current-year guidance.
The next 18-24 months depend on converting the pipeline. More than 1,000 keys are under development. Srinagar and Bandhavgarh are still guided for end CY27, with advanced mock-up rooms and civil work; Agra, Ayodhya, Sikkim and Ranthambore for CY28; Tadoba and BKC Mumbai for CY30. Jaisalmer and The Leela Luxury Residences Mumbai are in pre-opening, with Mumbai's first residents guided for Q4 FY27 after OC approvals. The five-hotel owned programme is now disclosed at ₹1,432 crore, and BKC carries ₹800 crore of committed hotel capex. The Q2 transcript's spend timetable for the five hotels is garbled, so the exact annual cash requirement cannot be mapped from the call alone.
Capital allocation is the second leg. Net debt was ₹12,150m at September 2026, and net debt/NTM EBITDA improved to 1.4x from 1.6x in March 2026. H1 finance cost fell 37%, and borrowing costs were cut another 30bps from mid-October. Management says it is comfortable with average leverage of 2.5x. That leaves headroom, but it is not unlimited. The BKC JV now plans to buy the full FSI and needs shareholder approval for a related-party investment; the total Leela commitment could rise above the ₹800 crore hotel capex. Dubai is a 25% JV with Brookfield, operationally EBITDA break-even in Q2 but still booking interest and depreciation losses; handover and a roughly 12-month renovation precede rebranding and any HMA fee. The $49m initial equity and $70m total equity including future capex are still expected to be recovered through branded-residence sales, but that is a future outcome, not a delivered cash return.
Management delivery is mixed but mostly transparent. It delivered the FY26 mid-to-high-teens EBITDA guidance, with operating EBITDA up 19% and margin at 49%. It missed the 0.3x net debt to EBITDA promise made at IPO; leverage reached 1.6x by FY26 and is now 1.4x, with the framework re-anchored to a 2.5x average. It acknowledged pipeline slippage, including Ranthambore's fortress stabilisation, and disclosed the BKC and Dubai structure changes with the prior commitments quoted. ARQ Chennai, earlier guided for April/Q2 FY27, is now scheduled for Q3 FY27. These are not fatal, but they argue for applying a haircut to new dates and for watching whether the capital-intensive projects stay within their stated envelopes.
The investment thesis therefore rests on three mechanisms. First, the owned palaces can keep compounding RevPAR at a premium to the luxury market because supply in their micro-markets remains constrained and the brand's NPS is high. Second, the management-fee stream can scale with high incremental margins as managed hotels ramp; new openings flow 85-90% into EBITDA. Third, the pipeline can add owned rooms in wildlife, heritage, spiritual and urban markets, but only if construction and approvals hold. The key falsifiers are concrete: H2 FY27 operating EBITDA growth falls below high teens; Q3 RevPAR growth fails to reach high double digits; net debt to EBITDA moves above the 2.5x average comfort level; BKC's FSI approval or total funding slips; Dubai's ADR and residence sales fail to recover after renovation; or Srinagar, Bandhavgarh and the CY28 hotels miss their stated windows. If those hold, the earnings base can compound without sacrificing the balance sheet. If they break, the FY30 target becomes an aspiration rather than an earnings path.
companyname: Leela Palaces Hotels & Resorts Limited (formerly known as Schloss Bangalore Limited) ticker: THELEELA sector: Luxury Hospitality Leela Palaces Hotels & Resorts Limited is India's only listed pure-play luxury hospitality company, owning, operating, managing and developing hotels and resorts under The Leela brand. It listed in June 2025. As of Q2 FY27, 15 hotels are operational and more than 1,000 keys are under development. Management targets over 5,200 keys by FY30, about half owne...
Read the full report →capex, margin expansion, acquisition inorganic
Management guides H2 FY27 operating EBITDA growth in high teens and Q3 FY27 RevPAR growth in high double digits. It says H1 was significantly ahead of the original FY27 double-digit RevPAR and mid-teens EBITDA guidance and that FY27 should be much better, without giving a new full-year number. The ₹2,000 crore FY30 EBITDA figure is a target/aspiration, not FY27 guidance.
Guidance upgradedoverdeliver
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Leela Palaces Hotels & Resorts Limited and 4,900+ companies.
5-day free pass. No card required.